ÂÜÀòÂÒÂ×

The Leadership Team at Asklepios BioPharmaceutical is responsible for guiding the company's strategic vision and operational execution in the development of AAV gene therapies. This team, comprised of executives from various disciplines such as scientific research, development, finance, and intellectual property, collaborates to drive innovation, ensure regulatory compliance, and navigate the complex landscape of the biotechnology industry. Their collective expertise helps to advance the organization's mission of delivering transformative therapies for genetic disorders.